Melanoma patients respond to a new HLA‐A01‐presented antigenic ligand derived from a multi‐epitope region of melanoma antigen TRP‐2

Tyrosinase‐related protein‐2 (TRP‐2) is a known target antigen of spontaneous cytotoxic T cell responses in melanoma patients. Its frequent expression in metastatic tumors suggests that it might be an ideal candidate antigen for T cell‐based immunotherapy. To provide knowledge about TRP‐2‐derived T...

Ausführliche Beschreibung